MICROBOT MEDICAL INC (MBOT)
US59503A2042 - Common Stock
Microbot Medical Shares Status Following Recent Geopolitical Events
Microbot Medical Shares Status Following Recent Geopolitical Events
All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in Israel Company...
MBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023
MBOT stock results show that Microbot Medical missed analyst estimates for earnings per share the fourth quarter of 2023.
MBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Microbot Medical (NASDAQ:MBOT) just reported results for the fourth quarter of ...
Microbot Medical files to sell 1M shares of common stock for holders (NASDAQ:MBOT)
Microbot Medical (MBOT) has filed a preliminary prospectus to sell around 1 million shares of common stock for holders.
Microbot files FDA application for clinical study of Liberty system (NASDAQ:MBOT)
Microbot Medical (MBOT) has filed an application with the FDA to begin a pivotal human clinical trial for its Liberty endovascular robotic surgical system. Read more here.
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application...
Microbot Medical announces settlement resolving legal matters (NASDAQ:MBOT)
Microbot Medical (MBOT) has reached a settlement agreement with Empery Asset Master Ltd.
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
All of the cash payable to the plaintiffs in the settlement will be covered by Microbot’s insurance carrier and will not impact company's cash position
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
All of the cash payable to the plaintiffs in the settlement will be covered by Microbot’s insurance carrier and will not impact company's cash position...
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical study
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical...
Microbot Medical files to sell 1.77M shares for its holders (NASDAQ:MBOT)
Microbot Medical files prospectus for resale of 11.33 million common shares by selling stockholders.
Microbot Medical down 22%, exercises investment options for $2.73M proceeds (NASDAQ:MBOT)
Microbot Medical (MBOT) has entered a definitive agreement to exercise outstanding preferred investment options, resulting in a reduced exercise price.
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
BRAINTREE, Mass., Dec. 29, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic...
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical study
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical study...
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
The first phase in the collaboration will evaluate the current state of the LIBERTY® Robotic Surgical System in connection with remote enabled Endovascular treatments
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
The first phase in the collaboration will evaluate the current state of the LIBERTY® Robotic Surgical System in connection with remote enabled Endovascular...
3 Stocks at the Forefront of Medical Robotics
Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid.
Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study
The final histopathology and lab report supplements previous positive Company findings. The results of the study will support the Company’s IDE...
Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities
The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase.
Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities
The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the...
Microbot Medical files for $75M mixed securities shelf (NASDAQ:MBOT)
Microbot Medical has filed a prospectus for the sale of $75M mixed securities shelf.